{"version":"1.0","type":"link","title":"BUB1B promotes gemcitabine resistance in lung adenocarcinoma and activates the PI3K/AKT signaling pathway.","author_name":"Zeng QF 외","author_url":"https://prs-insight.online/author/Zeng%20QF","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/101336","thumbnail_width":1200,"thumbnail_height":630}